Reprocell Inc.TSE: 4978

ReproCELL Incorporated Launches ReproRegistry to Strengthen Access to Human Skin Samples for Research

· Issued by Reprocell Inc.
Glasgow, UK - REPROCELL has announced the launch of ReproRegistry, a UK-based volunteer registry designed to accelerate skin research and drug discovery. The registry will enable both healthy volunteers and individuals diagnosed with skin conditions such as psoriasis and atopic dermatitis to participate in research studies and clinical trials. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Earlier from Reprocell

All Reprocell news releases